Zimmer BiometZBHEarnings & Financial Report
Zimmer Biomet Holdings, Inc. is a publicly traded American medical device company. It was founded in 1927 to produce aluminum splints. The firm is headquartered in Warsaw, Indiana, where it is part of the medical devices business cluster.
ZBH Q1 FY2026 Key Financial Metrics
Revenue
$2.1B
Gross Profit
$1.3B
Operating Profit
$373.2M
Net Profit
$238.3M
Gross Margin
64.6%
Operating Margin
17.9%
Net Margin
11.4%
YoY Growth
9.3%
EPS
$1.22
Zimmer Biomet Q1 FY2026 Financial Summary
Zimmer Biomet reported revenue of $2.1B (up 9.3% YoY) for Q1 FY2026, with a net profit of $238.3M (up 30.5% YoY) (11.4% margin). Cost of goods sold was $738.3M, operating expenses totaled $975.2M.
Key Financial Metrics
| Total Revenue | $2.1B |
|---|---|
| Net Profit | $238.3M |
| Gross Margin | 64.6% |
| Operating Margin | 17.9% |
| Report Period | Q1 FY2026 |
Zimmer Biomet Annual Revenue by Year
Zimmer Biomet annual revenue history includes year-by-year totals (for example, 2025 revenue was $8.2B).
Zimmer Biomet Quarterly Revenue & Net Profit History
Zimmer Biomet results over the last 8 reported quarters, including revenue, net profit and year-over-year growth.
| Quarter | Revenue | Revenue YoY | Net Profit | Net Margin |
|---|---|---|---|---|
| Q1 FY2026 | $2.1B | +9.3% | $238.3M | 11.4% |
| Q4 FY2025 | $2.2B | +10.9% | $139.4M | 6.2% |
| Q3 FY2025 | $2.0B | +9.7% | $230.9M | 11.5% |
| Q2 FY2025 | $2.1B | +7.0% | $152.8M | 7.4% |
| Q1 FY2025 | $1.9B | +1.1% | $182.0M | 9.5% |
| Q4 FY2024 | $2.0B | +4.3% | $239.5M | 11.8% |
| Q3 FY2024 | $1.8B | +4.0% | $249.1M | 13.7% |
| Q2 FY2024 | $1.9B | +3.9% | $242.8M | 12.5% |
Income Statement
| Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $1.94B | $1.82B | $2.02B | $1.91B | $2.08B | $2.00B | $2.24B | $2.09B |
| YoY Growth | 3.9% | 4.0% | 4.3% | 1.1% | 7.0% | 9.7% | 10.9% | 9.3% |
Balance Sheet
| Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | |
|---|---|---|---|---|---|---|---|---|
| Assets | $21.52B | $21.72B | $21.37B | $22.18B | $22.87B | $23.49B | $23.09B | $22.72B |
| Liabilities | $8.77B | $9.34B | $8.89B | $9.78B | $10.33B | $10.72B | $10.39B | $10.04B |
| Equity | $12.74B | $12.37B | $12.47B | $12.40B | $12.53B | $12.76B | $12.70B | $12.68B |
Cash Flow
| Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | |
|---|---|---|---|---|---|---|---|---|
| Operating CF | $369.4M | $395.7M | $506.3M | $382.8M | $378.2M | $418.7M | $517.4M | $359.4M |